{
  "id": "pvdl2",
  "display_name": "Peripheral Vasodilators, Exclude Dipyridamole (SHHS2)",
  "description": "Patient taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the SHHS2 visit.  All medications were recorded during the interview, and medication information was later categorized by physician review.",
  "type": "choices",
  "domain": "yesnof",
  "labels": [
    "PVDL2"
  ],
  "hybrid": {
    "VARNUM": "306",
    "TABLE": "SHHS2",
    "LABEL": "PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE",
    "access level": "0",
    "design_name": "Medication Form (SHHS2)",
    "MEMNAME": "shhs2_1",
    "most commonly used": null,
    "design_file": "SHHS2 Medications (MD).pdf",
    "PARENT TERM": null
  }
}
